Eproxindine

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E229K2HE7F. European Medicines Agency schedules Eproxindine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06588MIG. Eproxindine generally arises in the molecular formula C23H29N3O3. The term EPROXINDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, list 23.) EPROXINDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule eproxindine under HS 29339990 and SITC 51577. As of Q4 2014, EPROXINDINE remains US FDA's Preferred Term for this commodity. Eproxindine bears US NLM identifiers UMLS ID C0059470 and NCI Concept Code C81429. SMILES: OC(CN(CC)CC)CNC(=O)C1N(C2C(C1OC)CCCC2)C1CCCCC1.